Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

111 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Eligibility Cervical Cancer NCT00595725

- 01.08.16 - 1 Formular, 2 Itemgruppen, 18 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00595725

Registration Cervical Cancer NCT00262821

- 29.07.15 - 1 Formular, 5 Itemgruppen, 27 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, TRACKING INFORMATION, DEMOGRAPHIC INFORMATION, COMMENTS, FOOTER MODULE
Registration Form, Form R, GOG-0219 Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EF899EC7-4E6D-0D91-E034-0003BA3F9857

dbGaP phs000723 Sequencing of Cervical Cancer - Eligibility

- 06.01.23 - 5 Formulare, 1 Itemgruppe, 1 Datenelement, 1 Sprache
Itemgruppe: IG.elig
Principal Investigator: Yick Fu Wong, Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA MeSH: Uterine Cervical Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000723 Precision mapping of genetic alterations in cancer can enable better selection of therapies and improved outcomes when combined with new sequencing diagnostics. We describe whole-exome sequences from cervical adenocarcinomas and paired normal samples in Hong Kong Chinese women. These data uncover a heterogeneous genomic landscape but identify commonly aberrant loci including FAT1, ARID1A, ERBB2 and PIK3CA that may provide a focus for the development of individualized targeted therapies for Chinese women with cervical adenocarcinoma.

pht005210.v1.p1

1 Itemgruppe 5 Datenelemente

pht005211.v1.p1

1 Itemgruppe 5 Datenelemente

pht005212.v1.p1

1 Itemgruppe 7 Datenelemente

pht005213.v1.p1

1 Itemgruppe 12 Datenelemente

Cervical Cancer Cisplatin NCT00064077 GOG - Registration Form

- 15.03.21 - 1 Formular, 3 Itemgruppen, 28 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, TRACKING INFORMATION, Demographic Information
GOG Registration Form - 2058698v3.0 Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix https://clinicaltrials.gov/ct2/show/NCT00064077

Cervical Cancer Cisplatin NCT00064077 GOG - Pathology Form

- 26.06.17 - 1 Formular, 3 Itemgruppen, 29 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, DISEASE ASSESSMENT, SECONDARY DISEASE ASSESSMENT
GOG Pathology Form 2059039v3.0 Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix https://clinicaltrials.gov/ct2/show/NCT00064077

Cervical Cancer Cisplatin NCT00064077 GOG - Follow-Up Form

- 25.06.17 - 1 Formular, 7 Itemgruppen, 35 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, VITAL STATUS, PROGRESSION, BIOMARKERS, NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY
Follow-Up Form - 2059334v3.0 Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix https://clinicaltrials.gov/ct2/show/NCT00064077

Cervical Cancer Cisplatin NCT00064077 GOG - Solid Tumor Evaluation Form

- 24.06.17 - 1 Formular, 5 Itemgruppen, 33 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, TARGET LESION, NON-TARGET LESION, New Lesion Identification, OVERALL RESPONSE
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix https://clinicaltrials.gov/ct2/show/NCT00064077 Response - GOG Solid Tumor Evaluation Form - 2059416v3.0

Cervical Cancer Cisplatin NCT00064077 GOG - On Study Form

- 24.06.17 - 1 Formular, 4 Itemgruppen, 35 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, Past Medical HISTORY, Medical HISTORY, PRIOR TREATMENT Gynecologic Cancer
GOG Recurrent Gynecologic Cancer - On Study Form Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix On Study Form - 2058732v3.0

Cervical Cancer Cisplatin NCT00064077 GOG - Treatment Completion Form

- 24.06.17 - 1 Formular, 3 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, TREATMENT SCHEDULE, OFF-TREATMENT REASON
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix GOG Treatment Completion Form 2059221v3.0 https://clinicaltrials.gov/ct2/show/NCT00064077

Cervical Cancer Baseline assessment NCT00057928 - Baseline assessment Cervical Cancer NCT00057928 SWOG

- 28.03.15 - 1 Formular, 2 Itemgruppen, 15 Datenelemente, 1 Sprache
Itemgruppen: Header, TARGET LESIONS
SOUTHWEST ONCOLOGY GROUP BASELINE TUMOR ASSESSMENT FORM S0227 Comparison of Cisplatin Combined With Either Paclitaxel or Gemcitabine in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer NCT00057928 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A9C374FF-72CD-367D-E034-0003BA12F5E7

Cervical Cancer Registration SWOG S0227 NCT00057928 - Registration Form Cervical Cancer NCT00057928

- 27.09.21 - 1 Formular, 2 Itemgruppen, 29 Datenelemente, 1 Sprache
Itemgruppen: Header, Patient data
Southwest Oncology Group Registration Form (S0227) S0227 Comparison of Cisplatin Combined With Either Paclitaxel or Gemcitabine in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer NCT00057928 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A9C4563A-B1F7-3ACF-E034-0003BA12F5E7

Enrollment Cervical Cancer ANZGOG-0902 NCT01414608

- 04.08.15 - 1 Formular, 7 Itemgruppen, 39 Datenelemente, 1 Sprache
Itemgruppen: Header, Inclusion Criteria, Laboratory Eligibility Data, Consent, Exclusion Criteria, Stratification Factors, Footer Module
ANZGOG-0902 Enrollment Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90675395-7527-57AA-E040-BB89AD43454D

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video